The management of heart failure 5 years hence.
Leier
Carl V
CV
Department of Medicine, Division of Cardiovascular Medicine, The Ohio State University College of Medicine and Public Health, Columbus, OH 43210, USA. carl.leier@osumc.edu
Haas
Garrie J
GJ
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000639:trends*; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D006353:Heart-Assist Devices / Q000639:trends*; D006801:Humans; D011322:Primary Prevention / Q000639:trends*; D014481:United States
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics